BUFFALO, NY--(Marketwire - December 05, 2007) - Empire Genomics, developing high throughput technologies that enable genome-wide analyses to determine the underlying mechanisms for diseases, today announced the formation of its Scientific Advisory Board. The members of the new SAB represent a combination of scientific and medical expertise and clinical and operational experience in molecular genetics that will support the company as it develops diagnostic and research technologies for cancer biology, biomarkers, drug discovery, prenatal screening, developmental disorders, autism and other genomic related areas.
